Position in NVS
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$139,794
+$3,541 QoQ
Shares Held
892
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#1,345
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Smithfield Trust Co holds $61,006,231 across 17 Drug Manufacturers - General names. NVS ranks #10 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
79,661 | $20,231,503 | |
| 2 | MRK |
Merck & Co., Inc.
|
92,939 | $11,942,661 | |
| 3 | LLY |
ELI LILLY & Co
|
9,506 | $11,401,781 | |
| 4 | ABBV |
AbbVie Inc.
|
31,546 | $7,938,235 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
77,766 | $4,480,876 | |
| 6 | AMGN |
Amgen Inc
|
6,994 | $2,532,667 | |
| 7 | PFE |
Pfizer Inc
|
66,244 | $1,595,154 | |
| 8 | AZN |
Astrazeneca PLC
|
2,117 | $401,425 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $139,794 | 892 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $136,253 | 892 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $118,981 | 863 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $99,257 | 774 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $123,914 | 1,024 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $109,250 | 980 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $79,502 | 817 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $93,971 | 817 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $86,977 | 817 | Shares | Sole | 2024-07-31 | |
| 2024-03-31 | $80,285 | 830 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $82,492 | 817 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $291,420 | 2,861 | Shares | Sole | 2023-11-06 | |
| 2023-06-30 | $334,515 | 3,315 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $442,980 | 4,815 | Shares | Defined | 2023-05-11 | |
| 2022-12-31 | $436,816 | 4,815 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $386,509 | 5,085 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $515,717 | 6,101 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $446,208 | 5,085 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $479,772 | 5,485 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $448,563 | 5,485 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $500,451 | 5,485 | Shares | Sole | 2021-07-26 | |
| 2021-03-31 | $475,696 | 5,565 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $525,502 | 5,565 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $483,931 | 5,565 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $486,046 | 5,565 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $467,903 | 5,675 | Shares | Sole | 2020-05-05 | |
| No filing history on record for this holder in this stock. | ||||||